Short-term Perioperative Thromboprophylaxis After Major Abdominal Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

89 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-01

Study Completion Date

2020-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Major abdominal surgery for cancer is major risk factor for thromboembolism. Patients who undergo major abdominal surgery are prone to develop venous thromboembolism, both in the early postoperative period and after hospital discharger. There are strong recommendations in the international guidelines in favor to pharmacological thromboprophylaxis. Thus there is no consensus dor the duration of the prophylaxis. There are authors that suggest extended prophylaxis up to 4 week after surgery. On the other hand, there are prospective randomized trials that inpatient (short-term up to 7-10 days) prophylaxis is adequate.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer

NCT00660205

Thrombosis Deep Venous Thrombosis Pulmonary Embolism +4 more

COMPLETED

Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer

NCT01345773

Gastric Cancer Venous Thromboembolism Postoperative Period

COMPLETED

Venous Thromboembolism in Advanced Gastric Cancer Patients

NCT01047618

Advanced Gastric Cancer

COMPLETED

Deep Venous Thrombosis After Hepatobiliopancreatic Surgery

NCT02649023

Venous Thrombosis Pulmonary Embolism Hepatectomy +1 more

TERMINATED

Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery

NCT06302179

Colorectal Cancer Venous Thromboembolism

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a retrospective cohort study with 89 patients who underwent major abdominal surgery for colorectal and gastric cancer. All patients received short term prophylaxis (during hospital stay only) rather than extended prophylaxis (4 weeks). All participants received duplex ultrasound in the study period for the diagnosis of deep vein thrombosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deep Vein Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Retrospective Cohort

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AllPatients

There is only one cohort in this study. They all received the same follow up and ultrasound protocol.

Group Type OTHER

Duplex Ultrasound

Intervention Type DIAGNOSTIC_TEST

Duplex Ultrasound was performed for every participants for the diagnosis of symptomatic or asymptomatic deep vein thrombosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Duplex Ultrasound

Duplex Ultrasound was performed for every participants for the diagnosis of symptomatic or asymptomatic deep vein thrombosis

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Older than 18
* Major abdominal surgery gor colorectal or gastric cancer
* Caprini Risk score less than 9
* No history of anticoagulant treatment
* Thromboprophylaxis during hospital stay only